-+ 0.00%
-+ 0.00%
-+ 0.00%

Market news: The US FDA approved Pfizer PadCEV in combination with Keytruda for the treatment of muscle-invasive bladder cancer.

Zhitongcaijing·07/10/2026 15:33:06
Listen to the news
Market news: The US FDA approved Pfizer PadCEV in combination with Keytruda for the treatment of muscle-invasive bladder cancer.